Use of Immersive Virtual Reality and Therapeutic Exercise as Complementary Therapy in Mild to Moderate Parkinson's Disease (InViPark)
NCT ID: NCT07038590
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2024-09-05
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What does the participation consist of? The participation consists of carrying out 2/3 sessions per week on alternate days of physical exercise, and depending on whether the participant belong to the control or experimental group, the participant will do it regularly or recreated with a video game. The duration of each session will be 15 minutes. Be part of one group or another will depend on chance (like throwing a coin in the air and it comes up Heads or Cross). The total duration of the intervention in both cases is 3 months. During the project, 2 evaluations will be carried out: Initial evaluation and final evaluation. In all of them they will be collected information in relation to their pharmacological treatment linked to the pathology, autonomy functional balance, gait and risk of falls, functional balance, symptoms and disease monitoring and quality of life. Furthermore, in the experimental group the usability and security of the tool will be evaluated immersive virtual reality used. All these assessments will be carried out in your proximity center on the agreed day and time to optimize said process and will have an approximate duration of 30 minutes.
What discomforts or inconveniences does the participation have? The participation requires travel to your reference center to carry out the study. This program, like any physical activity or exercise, may involve greater tiredness and/or musculo-articular discomfort due to the type of exercise to which you will be subjected.
No relevant adverse effects have been recorded in the use of immersive virtual environments (video games).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease
NCT06052930
Effectiveness of Virtual Reality in Parkinson's Disease: Effects on Balance, Fall Risk, and Exercise Capacity.
NCT07251231
Effectiveness of Video-Based Upper Extremity Exercise Program in Parkinson's Disease
NCT06807411
Virtual Reality on Balance of Parkinson's Disease
NCT07274514
Usability Study of a Neuropsychological Intervention Program Based on Virtual Reality in Adults With Parkinson's Disease
NCT05403788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual treatment in patient association
Patients participate in memory, relaxation, and occupational therapy workshops.
usual treatment patient association
Common therapies in patient associations: memory workshops, relaxation, and occupational therapy
Exergame and virtual reality program + usual treatment
Weekly sessions (2) of exergame with virtual reality added to the usual treatment
exergame program with virtual reality
Participants who attend a patient association will add to their usual therapies or virtual exercise program to be developed 2 days a week for 3 months.
usual treatment patient association
Common therapies in patient associations: memory workshops, relaxation, and occupational therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exergame program with virtual reality
Participants who attend a patient association will add to their usual therapies or virtual exercise program to be developed 2 days a week for 3 months.
usual treatment patient association
Common therapies in patient associations: memory workshops, relaxation, and occupational therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Presenting a stage between 1 and 3 on the Hoehn and Yahr scale.
3. Being able to move around unaided.
4. Absence of dementia with a score on the Mini-Mental State Examination (MMSE) of 18 or higher.
5. Being between 30 and 70 years of age.
Exclusion Criteria
2. Severe visual and/or hearing disturbances that impede the session.
3. Having a history of vertigo, seizures, or epileptic seizures.
4. Presence of motor fluctuations and/or dyskinesias, gait blockages, or a history of recent falls.
5. Be receiving stable dopaminergic treatment without changes in the previous 3 months and with a prior plan not to change it during the duration of the study.
6. Be receiving second-line therapy (deep brain stimulation or intraduodenal pump).
7. Be participating in another clinical trial.
8. Not attend at least 80% of the immersive virtual reality sessions.
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vigo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pablo Campo-Prieto
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Vigo
Pontevedra, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IISGS
Identifier Type: OTHER
Identifier Source: secondary_id
HEALTHYFIT-UVIGO 1/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.